This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated HTRA2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HTRA2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~48.8 kDa | |
| Observed band | ~36 kDa | |
| Gel | 5–20% (catalog A01941-3) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Heart muscle (IHC candidate; verify WB) |
| PTM | Ubl conjugation + Cleaved | |
| Caveat | Mature versus precursor | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 4 isoform(s) |
The A01941-3 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human 293T, human HT-1080, human Hela (catalog A01941-3) |
| Gel % | 5–20% (catalog A01941-3) |
| Load | 30 ug; reducing conditions (catalog A01941-3) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A01941-3) |
| Membrane | nitrocellulose membrane (catalog A01941-3) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A01941-3) |
| Primary antibody | A01941-3 · 0.5 μg/mL (catalog A01941-3) |
| Primary incubation | overnight at 4°C (catalog A01941-3) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A01941-3) |
| Secondary incubation | 1.5 hour at RT (catalog A01941-3) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A01941-3) |
| Detection | ECL (catalog A01941-3) |
HTRA2 is predicted at 48.8 kDa and observed near 36 kDa; the cause of the difference is not established.
| Band near 36 kDa | Empirical HTRA2 band in reducing whole-cell blots; confirm identity with appropriate controls |
| Band near 48.8 kDa | Possible full-length precursor near the UniProt predicted mass |
| Band below the precursor | Propeptide cleavage could yield a smaller mature protein |
| Several bands at different positions | Isoforms 1, 2, 3 and 4 or processing could contribute; distinct bands are not established |
| UniProt predicted precursor mass | Predicts 48.8 kDa; the empirical HTRA2 band is near 36 kDa |
| Propeptide residues 32..133 | Cleavage can make mature HTRA2 smaller than its precursor; its observed migration is not established by this feature alone |
| Splice isoform 1 | May differ in size from the other named isoforms; its mass is not supplied |
| Splice isoforms 2, 3 and 4 | May differ in size from isoform 1 or each other; their masses are not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Mitochondrial HTRA2 may be poorly recovered | Check mitochondrial enrichment and a positive-control lysate |
| Band higher than expected | Full-length precursor may remain alongside the band near 36 kDa | Compare precursor and mature forms with a validated HTRA2 control |
| Band lower than expected | Propeptide processing could produce a smaller form | Compare with the band near 36 kDa and confirm identity by HTRA2 depletion |
| Multiple bands | Alternative splicing or processing may contribute | Use HTRA2 depletion and isoform-specific controls where available |
| Weak or no signal | Mitochondrial recovery or HTRA2 abundance may be low | Check loading, mitochondrial recovery and a positive control |
| Fragments below expected size | HTRA2 has an autocatalytic cleavage annotation; sample degradation is also possible | Use fresh lysate with protease inhibitors and confirm fragments by HTRA2 depletion |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Heart muscle | cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Ovary | ovarian stroma cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
| Spleen | cells in red pulp | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for HTRA2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-HTRA2 antibodies have WB images using human cell lysates. A01941-3 reports a band near 36 kDa across four human cell lines; M01941 shows Jurkat lysate, and A01941 shows U937 lysate. The supplied images do not demonstrate mouse or rat samples.
Which to pick: For human lysates, A01941-3 has the most detailed reported WB conditions; A01941 provides U937 data at three antibody concentrations. M01941 lists human, mouse, and rat reactivity, but its supplied WB image uses human Jurkat lysate. All three have WB images.